| 000 | 01507 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250518002736.0 | ||
| 264 | 0 | _c20190517 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a1872-8057 | ||
| 024 | 7 |
_a10.1016/j.mce.2018.10.009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSbiera, Silviu | |
| 245 | 0 | 0 |
_aHsp90 inhibition in adrenocortical carcinoma: Limited drug synergism with mitotane. _h[electronic resource] |
| 260 |
_bMolecular and cellular endocrinology _c01 2019 |
||
| 300 |
_a36-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAdrenocortical Carcinoma _xdrug therapy |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aComputer Simulation |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 |
_aHSP90 Heat-Shock Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aHeterocyclic Compounds, 2-Ring _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMitotane _xpharmacology |
| 650 | 0 | 4 |
_aPyrazoles _xpharmacology |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 700 | 1 | _aKendl, Sabine | |
| 700 | 1 | _aWeigand, Isabel | |
| 700 | 1 | _aSbiera, Iuliu | |
| 700 | 1 | _aFassnacht, Martin | |
| 700 | 1 | _aKroiss, Matthias | |
| 773 | 0 |
_tMolecular and cellular endocrinology _gvol. 480 _gp. 36-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.mce.2018.10.009 _zAvailable from publisher's website |
| 999 |
_c28933875 _d28933875 |
||